JP Morgan Chase & Co’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $401K | Sell |
|
|||||
|
2025
Q2 | $453K | Buy |
|
|||||
|
2025
Q1 | $417K | Buy |
|
|||||
|
2024
Q4 | $438K | Sell |
|
|||||
|
2024
Q3 | $242K | Buy |
|
|||||
|
2024
Q2 | $175K | Sell |
|
|||||
|
2024
Q1 | $244K | Sell |
|
|||||
|
2023
Q4 | $600K | Buy |
|
|||||
|
2023
Q3 | $420K | Buy |
|
|||||
|
2023
Q2 | $482K | Buy |
|
|||||
|
2023
Q1 | $495K | Buy |
|
|||||
|
2022
Q4 | $407K | Buy |
|
|||||
|
2022
Q3 | $452K | Buy |
|
|||||
|
2022
Q2 | $408K | Sell |
|
|||||
|
2022
Q1 | $511K | Buy |
|
|||||
|
2021
Q4 | $578K | Buy |
|
|||||
|
2021
Q3 | $440K | Sell |
|
|||||
|
2021
Q2 | $763K | Buy |
|
|||||
|
2021
Q1 | $334K | Sell |
|
|||||
|
2020
Q4 | $339K | Buy |
|
|||||
|
2020
Q3 | $93K | Sell |
|
|||||
|
2020
Q2 | $206K | Buy |
|
|||||
|
2020
Q1 | $43K | Sell |
|
|||||
|
2019
Q4 | $36K | Hold |
|
|||||
|
2019
Q3 | $44K | Buy |
|
|||||
|
2019
Q2 | $38K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $22K | Sell |
|
|||||
|
2017
Q4 | $26K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $105K | Buy |
|